Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesPharmacy & Specialty DrugsSelectHealth formulary coverage & Prior Auth | Ope…
    Ask Trek AI about this page
    CurrentSelectHealthPolicy N/A

    Prescription drug list (formulary) - Coverage Criteria

    Customize your policy alerts

    Sign up for all SelectHealth policy alerts

    Know when SelectHealth releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Summarizes commonly prescribed drugs covered by SelectHealth plans, explains tiers, cost-sharing, and administrative controls (e.g., prior authorization, step therapy, quantity limits) for members and providers.

    Policy Summary
    PayerSelectHealth
    PolicyPrescription drug list (formulary) - Coverage Criteria
    Policy CodePolicy N/A
    Change TypeNo material changes
    Effective DateJan 1, 2026
    Next Review Date
    Key ActionObtain prior authorization from SelectHealth before coverage for drugs flagged with (PA).
    SourceLink

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    monthlyformulary review frequency
    90-daymaintenance drug supply option referenced
    PA, QL, M, ST, AGEauthorization flags observed
    1/1/2026document effective date

    Coverage rules and general formulary guidance

    General coverage rule per listed requirement flags

    Covered when ALL of the following are met:

    Standard formulary coverage conditions: Item is covered at the assigned tier when all listed administrative requirements are satisfied

    Administrative requirement flags include: (PA) prior authorization, (QL) quantity limits, (ST) step therapy, (M) maintenance/medical-necessity review, (AGE) age limits. See item-level Requirements & Limits for flags applicable to the specific product.

    Some drugs in the formulary are designated as noncovered. For those items, members, their prescribing physician, or the dispensing pharmacy may request coverage by submitting a Drug Coverage Exception Form and providing documentation of medical necessity. Requests for noncovered drug coverage are considered on a case‑by‑case basis.

    Within the provided extract there are no explicit exclusion lists shown that categorically remove specific drug classes or products from coverage; formulary entries instead show tier assignments and utilization flags (e.g., PA, QL, M, ST, AGE) that govern coverage conditions.

    The source segments reviewed do not include any statements explicitly labeling products as not medically necessary. Coverage determinations in this extract are driven by tier assignments and administrative requirement flags rather than explicit 'not medically necessary' language.

    Formulary entries, tiers, and flags (coding view)

    Formulary entries (no billing codes provided in this section)mixed
    No codes listed
    Formulary tier and requirement flagsmixed
    Tier 2Drug Tier = 2 (assigned to multiple entries such as Glipizide, Fluorouracil Cream in one line, etc.)
    PAPrior Authorization requirement flag
    QLQuantity Limit requirement flag
    MRequirement flag (document-specific)
    Utilization management flagsmixed
    STStep Therapy requirement flag
    AGEAge limit flag
    inv-08: Age limit (AGE)
    AGE marker presentDocument flags an AGE requirement for some products, but specific minimum/maximum ages are not listed in the extracted chunks
    ImplicationWhen (AGE) appears in Requirements & Limits, member age verification will be required to determine coverage
    Examples referencedMultiple device and vaccine entries show (AGE) (e.g., Free Libre2 Kit, Dexcom G7, Gardasil 9) but exact age thresholds are not included here

    What providers must do (authorizations, documentation, step therapy)

    Prior Authorization

    Prior authorization required

    Coverage of certain drugs requires prior authorization (PA) before the plan will pay. If a drug is marked with (PA) in the formulary, obtain PA prior to dispensing — otherwise the member may be held responsible for the drug's full retail cost and the claim may be denied.

    • Examples: Repatha, Mounjaro, Trulicity, Soliqua and other products shown with (PA) in the formulary.
    • Claims submitted without required PA are subject to denial or member liability.
    Note

    Authorization-related flags (PA, ST, QL, M, AGE)

    Entries flagged with administrative indicators — (PA), (ST), (QL), (M), (AGE) — indicate program controls that affect coverage. Review the formulary flags carefully and meet the associated requirements when prescribing or dispensing.

    • (PA) = Prior authorization required.
    • (ST) = Step therapy required (trial/failure of specified alternatives).

    Formulary structure and scope

    The formulary groups medications by clinical category and assigns each item a drug tier that determines cost sharing. A clinical/pharmacy review team evaluates efficacy, safety, and cost‑effectiveness on a recurring schedule to maintain the list. Administrative controls — including prior authorization (PA), quantity limits (QL), step therapy (ST), maintenance (M), and age limits (AGE) — are applied at the item level and must be satisfied for coverage at the assigned tier.

    Key flags and terms

    inv-32: Preauthorization (PA) definition
    DefinitionPreauthorization (PA) = Authorization required from the payer before coverage is approved for certain drugs
    Effect of not obtaining PAIf preauthorization is not obtained where required, the member may be responsible for the drug's full retail price
    Where shownItems flagged (PA) in the Requirements & Limits column require prior authorization prior to coverage
    inv-33: Maintenance drug (M) — 90-day supply reference
    DefinitionMaintenance drug (M) = Drugs designated for maintenance therapy that may be available in a 90-day supply
    PurposeDesigned for ongoing therapy convenience (90-day supply option)

    Drugs subject to step therapy requirements

    RequirementDescription / Policy
    Step therapy (ST)
    Drugs marked with (ST) require trial and failure of an alternative (preferred) therapy before the requested drug is covered; step therapy most often applies to brand‑name drugs.
    Agent(s)Requirements noted
    Diltiazem (e.g., Dilt‑XR, Diltiazem Er)
    Listed with requirement flags including (ST)(QL)(M) or (M) depending on formulation — indicates step therapy may apply to some Diltiazem products.
    Icosapent / Omega‑3 Acid Capsule
    Example entries show Requirements & Limits = (ST) or blank depending on item; referenced as therapies with ST indicated in formulary segments.
    Benzonatate
    Included among items in formulary segments where (ST)(QL) or (ST) flags appear — denoting step therapy may apply to some formulations.
    When (ST) is presentPolicy implication
    Requirements & Limits column includes (ST)
    Products with (ST) require documentation of prior trial and failure of preferred agent(s) before coverage is approved; prior steps must be documented per formulary rules.
    ContextAction required
    Formulary entries where (ST) indicated (e.g., diabetes testing & supplies and device kit listings; other therapeutic areas)
    Step therapy is required for drugs/items flagged with (ST); providers must document that required prior therapies were tried and failed (or were not tolerated) before the requested product will be covered.
    ProductRequirement flags
    Levothyroxin
    Requirements & Limits = (ST)(QL)(M) — indicates step therapy may be required for some Levothyroxin formulations in addition to quantity limits and medical necessity review.

    Products subject to quantity limits

    inv-62: Auvi-Q Injectable / Epinephrine Injectable — QL applies (examples)
    Auvi-Q / Epinephrine QL exampleAuvi-Q Injectable and Epinephrine Injectable are listed with (QL) in Requirements & Limits
    ImplicationQuantity limits apply to epinephrine auto-injectors per the formulary extract
    ReferenceSee formulary dermatologic/anaphylaxis entries for QL usage
    inv-63: Paxlovid — QL indicated
    Paxlovid QLPaxlovid is indicated with (QL) in the Requirements & Limits column
    PlacementPaxlovid appears in the antiviral section with QL noted
    Policy Summary
    PayerSelectHealth
    PolicyPrescription drug list (formulary) - Coverage Criteria
    Policy CodePolicy N/A
    Change TypeNo material changes
    Effective DateJan 1, 2026
    Next Review Date
    Key ActionObtain prior authorization from SelectHealth before coverage for drugs flagged with (PA).
    SourceLink
    On This Page
    Coverage rules and general formulary guidanceFormulary entries, tiers, and flags (coding view)What providers must do (authorizations, documentation, step therapy)Formulary structure and scopeKey flags and termsDrugs subject to step therapy requirementsProducts subject to quantity limits
  1. (QL) = Quantity limits apply; requests above limits may need PA.
  2. (M) = Medical necessity criteria apply.
  3. (AGE) = Age limits — member age must meet criteria.
  4. Step Therapy

    Step therapy requirement (ST)

    When (ST) appears next to a drug, the product requires step therapy. Coverage is provided only after documented trial and inadequate response or intolerance to required first-line alternatives. Include prior-treatment documentation when requesting PA for step-therapy drugs.

    • Examples of drugs with (ST): some statins, levothyroxine entries, and other branded products shown with (ST).
    • Provide dates, drugs tried, reason for failure or intolerance, and any relevant lab results when supporting a step-therapy exception request.
    Documentation Required

    Documentation required for age limits (AGE)

    Age limits (AGE) shown in the formulary must be documented in any prior authorization or exception submission. If a product is flagged (AGE) you must confirm the member meets the age-based criteria to receive coverage.

    • Examples: vaccines and selected chronic therapies in the formulary list include (AGE) indicators.
    • Include member date of birth and relevant clinical rationale when submitting PA or exception requests.
    Flag usageThe (M) flag appears in Requirements & Limits to denote maintenance status for selected products
    inv-34: Step Therapy (ST) definition
    DefinitionStep Therapy (ST) = Coverage condition requiring trial and failure of a specified alternative therapy before the requested drug is covered
    Typical applicationMost often applies to brand‑name drugs; prior steps must be documented
    ConsequenceDrugs with (ST) require evidence of prior therapy failure or adverse reaction to preferred agents
    inv-35: Quantity Limits (QL) definition
    DefinitionQuantity Limits (QL) = Plan-imposed limits on drug quantities; exceeding the limit may require prior authorization
    ScopeApplied to selected drugs (e.g., opioids, injectables, vaccines) to limit amount dispensed in a time period
    Operational noteClaims exceeding QL may be subject to denial or require PA per formulary rules
    inv-36: Age limit (AGE) definition
    DefinitionAge limit (AGE) = A minimum or maximum age requirement must be met for coverage of certain drugs
    DocumentationWhen (AGE) appears, supporting age documentation will be required to determine coverage eligibility
    Appearance in tableAGE appears in Requirements & Limits for vaccines, devices, and medications in the formulary extract
    inv-37: PA (short)
    PA (short)Prior authorization required before coverage
    When usedShown as (PA) in Requirements & Limits for affected drugs
    ConsequenceNo PA may result in member financial responsibility
    inv-38: QL (short)
    QL (short)Quantity limit applies; may restrict amount dispensed per time period
    When usedShown as (QL) for selected products (e.g., Auvi-Q, vaccines, injectables)
    ConsequenceExceeding QL may require prior authorization or be denied
    inv-39: M (short)
    M (short)Maintenance drug — may be dispensed as a 90-day supply
    When usedFlagged as (M) in Requirements & Limits to denote maintenance status
    PurposeIndicates chronic or ongoing therapy where extended supply is appropriate
    inv-40: ST (short)
    ST (short)Step therapy required — trial and failure of preferred agent(s) first
    When usedFlagged as (ST) in Requirements & Limits for affected drugs
    DocumentationPrior steps and rationale for failure or intolerance must be documented
    inv-41: AGE (short)
    AGE (short)Age-based coverage limitation — minimum or maximum age applies
    When usedDisplayed as (AGE) in the Requirements & Limits column for certain products
    Provider actionVerify and document member age to support coverage determinations
    inv-42: Prior Authorization required (alternate)
    Prior Authorization required (alternate)PA indicates payer approval must be obtained before coverage; absence may result in member paying full retail price
    Usage noteApplied to specific drugs as shown in the Requirements & Limits column
    Example actionSubmit PA request to SelectHealth prior to dispensing when (PA) is shown
    inv-43: Quantity Limit (alternate)
    Quantity Limit (alternate)QL denotes plan-imposed dispensing limits; vaccines and many injectables list (QL) in Requirements & Limits
    Operational impactClaims over QL may be denied or require PA per formulary rules
    ExamplesFluzone and many influenza vaccines show (QL) in the extract
    inv-44: Step Therapy (alternate)
    Step Therapy (alternate)ST requires trial of preferred therapy first; often applies to brand-name agents
    Documentation requirementEvidence of prior therapy failure or intolerance must be provided to satisfy ST
    Result if unmetCoverage may be denied until step requirements are met
    inv-45: M flag — may indicate medical management or miscellaneous requirement
    M flag meaningMay indicate medical management or miscellaneous requirement — used to denote drugs/devices needing additional review
    Context(M) appears alongside PA/QL/ST flags for items requiring extra documentation or ongoing management
    Provider actionBe prepared to supply clinical rationale or documentation when (M) is present
    inv-46: AGE — age limit applies
    AGE appliesAGE flag indicates an age limit applies to coverage for the listed drug or product
    Where seenAGE is used across the formulary including dermatologics and vaccines in the extracted chunks
    RequirementSupporting age documentation is expected when AGE is flagged
    inv-47: PA (definition instance)
    PA (definition instance)PA = Preauthorization required from SelectHealth prior to coverage approval
    ConsequenceWithout required PA the claim may be denied or member may pay full retail price
    ApplicationApplied to specific injectable and specialty products as shown in Requirements & Limits
    inv-48: QL (definition instance)
    QL (definition instance)QL = Quantity Limit applied to a drug, limiting amount dispensed in a given time period
    Interaction with PAPreauthorization is required if dispensing exceeds the plan limit
    Applied toExamples include injectables, vaccines, and certain chronic medications
    inv-49: M (definition instance)
    M (definition instance)M = Maintenance drug designation; may allow dispensing up to a 90-day supply
    Intended useFor chronic therapy where longer supply is clinically appropriate
    Flag presence(M) appears in Requirements & Limits to identify maintenance products
    inv-50: ST (definition instance)
    ST (definition instance)ST = Step Therapy requiring trial and failure of a preferred alternative before coverage
    Typical scenarioOften used for higher-cost brand agents to encourage use of preferred therapies first
    DocumentationProvider must document prior trials and outcomes to meet ST requirements
    inv-51: AGE (definition instance)
    AGE (definition instance)AGE = Minimum or maximum age requirement must be met for coverage of certain drugs or products
    EvidenceAge verification/documentation will be requested when AGE is shown
    Commonly appliedUsed for vaccines, pediatric formulations, and some devices in the formulary extract
    inv-52: PA (definition instance)
    PA (definition instance)Prior authorization indicates payer approval required before coverage — listed as (PA) in Requirements & Limits
    ExamplesRepatha Injectable and other biologics are listed with (PA) in the extract
    Provider implicationObtain PA from SelectHealth before dispensing PA‑flagged agents
    inv-53: QL (definition instance)
    QL (definition instance)QL = Plan quantity restriction; vaccines and many injectables show (QL) in Requirements & Limits
    EffectLimits define allowed dispensing frequencies/amounts and may trigger denials if exceeded
    ExamplesFluzone and other influenza vaccines are shown with (QL) in the extract
    inv-54: AGE (definition instance)
    AGE (definition instance)AGE = Age-based coverage limitation; the formulary requires age criteria for some items
    Where appliedAppears across therapeutic categories including dermatologics and cardiovascular agents in the extracted chunks
    DocumentationProviders should verify age and include supporting documentation when required
    inv-55: M (definition instance)
    M (definition instance)M = Maintenance; indicates drugs appropriate for ongoing therapy and potential 90-day dispensing
    ExamplesAppears for many chronic therapy products and diabetes supplies in the extract
    Operational note(M) may trigger different dispensing options and documentation expectations
    inv-56: ST (definition instance)
    ST (definition instance)ST = Step Therapy; trial of preferred agent(s) required first and documentation of failure/intolerance needed
    ExamplesDiltiazem and other agents show (ST) with additional flags (QL)(M) in the extract
    ConsequenceCoverage may be denied until step criteria are satisfied
    Operational note
    Dispensing of Paxlovid may be subject to quantity limits per formulary rules
    inv-64: Repatha Injectable — QL indicated
    Repatha QLRepatha Injectable is listed with (PA)(QL)(M) indicating quantity limits apply (among other flags)
    ContextRepatha appears in lipid therapy entries with PA and M flags alongside QL
    Provider implicationPrior authorization and adherence to QL will be required for Repatha claims
    inv-65: Mounjaro Injectable — QL indicated
    Mounjaro QLMounjaro Injectable is listed with (PA)(QL)(M) indicating quantity limits apply
    Additional flagsAlso requires prior authorization and is flagged as maintenance in some entries
    Operational impactDispensing of Mounjaro will follow PA and QL enforcement per formulary rules
    inv-66: Fluorouracil Cream — QL indicated
    Fluorouracil Cream QLFluorouracil Cream is listed with (PA)(QL) indicating quantity limits apply
    CategoryListed under dermatologicals with PA and QL flags
    Provider notePA and QL must be considered when requesting coverage for fluorouracil cream
    inv-67: Trulicity Injectable — QL indicated
    Trulicity QLTrulicity Injectable appears with (PA)(QL)(M) indicating quantity limits apply
    ContextListed in diabetes injectable entries with maintenance and PA flags
    Provider actionPA and QL compliance required for coverage of Trulicity
    inv-68: multiple entries flagged with (QL) — per formulary QL
    Multiple QL entriesNumerous formulary entries are flagged with (QL) indicating per‑formulary quantity limits apply
    ScopeQL appears across categories including testing supplies, injectables, and chronic meds
    Operational noteClaims exceeding these limits may require PA or be denied
    inv-69: Fluzone Injectable — (QL)
    Fluzone QLFluzone Injectable is shown with (QL) in Requirements & Limits
    CategoryAppears in vaccine listings where QL is commonly applied
    Provider implicationVaccine dispensing may be limited per QL and require documentation
    inv-70: Gardasil 9 Injectable — (AGE) flagged (age-specific limits)
    Gardasil 9 AGE flagGardasil 9 Injectable is listed with (AGE) indicating age‑specific limits apply
    ImplicationPatient age must meet the formulary age criteria for Gardasil 9 to be covered
    DocumentationProviders must verify and document patient age when AGE is flagged for Gardasil 9
    inv-71: Pedia Iron Dro — (QL)(AGE)
    Pedia Iron Dro QL/AGEPedia Iron Dro is listed with (QL)(AGE) indicating both quantity limits and age restrictions apply
    CategoryPediatric iron formulations show combined QL and AGE flags in the extract
    Provider actionVerify patient age and adhere to QL when dispensing pediatric iron drops